Cogent Biosciences Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 23.09 M | $820.05 M | 3.03% | 20.17% |
| BLACKROCK, INC. | 02/12/2026 | 12.97 M | $460.86 M | 25.12% | 19.19% |
| VANGUARD GROUP INC | 01/29/2026 | 11.51 M | $408.99 M | 48.43% | 17.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 9.04 M | $321.24 M | -0.10% | 13.38% |
| RTW INVESTMENTS, LP | 02/17/2026 | 7.59 M | $269.68 M | 118.96% | 11.23% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/17/2026 | 9.00 M | $319.80 M | 0.00% | 7.87% |
| STATE STREET CORP | 02/13/2026 | 4.94 M | $175.48 M | 3.45% | 7.31% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 6.17 M | $218.99 M | -21.82% | 5.39% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 3.51 M | $124.86 M | 7.34% | 5.20% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 5.87 M | $208.44 M | -13.68% | 5.13% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.54 M | $161.11 M | 42.77% | 3.96% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 2.56 M | $91.08 M | 2,757.98% | 3.79% |
| VIVO CAPITAL, LLC | 02/13/2026 | 2.40 M | $85.21 M | -13.99% | 3.55% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 2.35 M | $83.47 M | -18.24% | 3.48% |
| DUQUESNE FAMILY OFFICE LLC | 02/17/2026 | 2.21 M | $78.66 M | 109.00% | 3.28% |
| COMMODORE CAPITAL LP | 02/17/2026 | 2.20 M | $78.03 M | -69.70% | 3.25% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.71 M | $60.57 M | 2.74% | 2.52% |
| MARSHALL WACE, LLP | 02/13/2026 | 1.66 M | $58.99 M | 158.49% | 2.46% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 2.71 M | $96.34 M | 566.59% | 2.37% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.44 M | $51.11 M | -13.72% | 2.13% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 2.25 M | $79.84 M | 46.83% | 1.96% |
| CANDRIAM S.C.A. | 04/30/2026 | 1.30 M | $46.05 M | 35.87% | 1.92% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.21 M | $42.92 M | 191.16% | 1.79% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.19 M | $42.34 M | -46.77% | 1.76% |
| VR ADVISER, LLC | 02/17/2026 | 2.00 M | $71.04 M | -50.00% | 1.75% |
| HOLOCENE ADVISORS, LP | 02/17/2026 | 1.18 M | $41.85 M | 899.19% | 1.74% |
| 02/17/2026 | 1.17 M | $41.58 M | 100.00% | 1.73% | |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 1.97 M | $70.10 M | -7.25% | 1.72% |
| LORD, ABBETT & CO. LLC | 02/13/2026 | 1.87 M | $66.44 M | 100.00% | 1.63% |
| FRED ALGER MANAGEMENT, LLC | 02/17/2026 | 1.10 M | $39.15 M | 100.00% | 1.63% |
| SIREN, L.L.C. | 02/13/2026 | 1.63 M | $57.87 M | -5.51% | 1.42% |
| EMERALD ADVISERS, LLC | 02/09/2026 | 1.58 M | $56.24 M | 0.24% | 1.38% |
| NUVEEN, LLC | 02/12/2026 | 932.62 K | $33.13 M | -0.74% | 1.38% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 892.92 K | $31.72 M | 100.00% | 1.32% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 1.44 M | $51.16 M | -46.07% | 1.26% |
| REDMILE GROUP, LLC | 02/17/2026 | 1.44 M | $51.07 M | -34.91% | 1.26% |
| WOODLINE PARTNERS LP | 02/17/2026 | 818.78 K | $29.08 M | 59.48% | 1.21% |
| 02/17/2026 | 780.00 K | $27.71 M | 100.00% | 1.15% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 1.28 M | $45.49 M | 7.57% | 1.12% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 1.25 M | $44.23 M | 52.78% | 1.09% |
| MORGAN STANLEY | 02/13/2026 | 726.78 K | $25.82 M | -43.58% | 1.08% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.22 M | $43.23 M | -39.90% | 1.06% |
| NORTHERN TRUST CORP | 02/17/2026 | 1.20 M | $42.60 M | 1.49% | 1.05% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 689.07 K | $24.48 M | 195.78% | 1.02% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 668.97 K | $23.76 M | 100.00% | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/09/2026 | 1.04 M | $36.89 M | 1.53% | 0.91% |
| INVESCO LTD. | 02/19/2026 | 585.77 K | $20.81 M | 57.35% | 0.87% |
| 02/13/2026 | 568.62 K | $20.20 M | 100.00% | 0.84% | |
| ATIKA CAPITAL MANAGEMENT LLC | 02/13/2026 | 506.00 K | $17.97 M | 100.00% | 0.75% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 849.03 K | $30.16 M | -15.80% | 0.74% |
Cogent Biosciences Inc institutional Ownership - FAQ's
During the previous two years, 343 institutional investors and hedge funds held shares of Cogent Biosciences Inc. The most heavily invested institutionals were:
Invesco Ltd.: 2.43 M
Pictet Asset Management Holding SA: 1.8 M
EMERALD ADVISERS, LLC: 1.59 M
Candriam S.C.A.: 1.52 M
VANGUARD FIDUCIARY TRUST CO: 1.06 M
EMERALD MUTUAL FUND ADVISERS TRUST: 1.03 M
257.52% of Cogent Biosciences Inc stock is owned by institutional investors.
Institutional investors have bought a total of 187.92 M shares in the last 24 months. This purchase volume represents approximately $6.95 B in transactions.